| ICCC Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ICCC shares outstanding history going back to 3/26/2010:
Also see: ICCC Market Cap History ICCC YTD Return |
ICCC Shares Outstanding History — ImmuCell Share Count Over Time
As of 5/1/2026 ImmuCell has 9.05 million ICCC shares outstanding. Investors often track the ICCC shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ICCC share count trends over time, with 65 historical shares outstanding datapoints presented, dating back to 3/26/2010.
| ICCC Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ICCC Historical Shares Outstanding: +7.16% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ICCC Stock Price Chart |
| About ImmuCell Corp. |
| ImmuCell Corporation is an animal health company. Co. is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the U.S. Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. We show 65 historical shares outstanding datapoints in our coverage of ICCC's shares outstanding history. Understanding the changing numbers of ICCC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ICCC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ICCC by allowing them to research ICCC shares outstanding history as well as any other stock in our coverage universe. |
| ICCC Current Stock Quote |
Quotes delayed 20 minutes  Free ICCC Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ICCC Share Performance |
| Shares Outstanding Peers |
| ImmuCell (ICCC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ICLR Shares Outstanding History ICPT Shares Outstanding History ICUI Shares Outstanding History ICVX Shares Outstanding History IDRA Shares Outstanding History IDXG Shares Outstanding History IDXX Shares Outstanding History IDYA Shares Outstanding History IGAP Shares Outstanding History IGMS Shares Outstanding History More Healthcare companies » |
ICCC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
